Advanced Oncotherapy (AVO)

 

AVO Share PerformanceMore

52 week high138.000 26/07/16
52 week low9.525 19/07/17
52 week change -112.850 (-88.16%)
4 week volume8,947,395 29/06/17

Media for (AVO)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Result of AGM

RNS Number: 5467L Advanced Oncotherapy PLC 19 July 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Result of AGM Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that at the Annual General Meeting held earlier today, all resolutions were ...

Financing facility by significant shareholders

RNS Number: 4877L Advanced Oncotherapy PLC 19 July 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Financing Facility provided by significant shareholders Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that a consortium formed by AB ...

Video and update on progress at Harley Street

RNS Number: 0913K Advanced Oncotherapy PLC 05 July 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Video and update on progress at Harley Street Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the release of a short video providing an upd...

Advanced Oncotherapy - Harley Street update with Deconstruct UK

Final Results

RNS Number: 0808J Advanced Oncotherapy PLC 26 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Final Results for the year ended 31 December 2016 Advanced Oncotherapy (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces audited results for the year ended 31 De...

Conversion of Convertible Loan Notes

RNS Number: 6618I Advanced Oncotherapy PLC 21 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Conversion of Convertible Loan Notes Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Bracknor Investment Group ("Bracknor") has a...

Advanced Oncotherapy appoints senior VP of medical physics

Advanced Oncotherapy, the developer of next-generation proton therapy systems for cancer treatment, has appointed Dr. J...

Appointment of Senior VP of Medical Physics

RNS Number: 0043I Advanced Oncotherapy PLC 14 June 2017 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Appointment of Senior Vice-President of Medical Physics Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the appointment of Dr. Jonathan...

Fundamental DataMore

EPS-17.01
Dividend yield0 %

Equity Research (AVO)

hardman & co
Advanced Oncotherapy Plc
15/03/2017
AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage...
Advanced Oncotherapy Plc
27/02/2017
PowerHouse Energy Group (PHE.L) 1p £8.94m PowerHouse has agreed with University of Chester to deploy its G3-UHt unit (ultra-high temperature demonstration gasification system)  at its Thornton...
hardman & co
Advanced Oncotherapy Plc
02/11/2016
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its...

Latest discussion posts More

  • Interesting RNS

    So looks like some shareholders thought, hang on a minute I'm seeing my holding dwindle here and I can get a piece of the action and stop my dilution with a better deal for ...
    19-Jul-2017
    fish lips
  • Re: Last Tranch from Bracknor?

    Bracknor waived the requirement to reduce the nominal: http://www.investegate.co.uk/advanced-oncotherapy--avo-/rns/update-on-bracknor-financing/201706051445381774H/ Now ...
    30-Jun-2017
    JakNife
  • Re: Last Tranch from Bracknor?

    JakNife, No sign of that General Meeting you mentioned. The sp has been below 25p since the 19th May, so way over the 10 days set. From what I can see they are not in ...
    30-Jun-2017
    Kenj2

Users' HoldingsMore

Users who hold Advanced Oncotherapy also hold..
LLOYDS GRP.22%
SIRIUS MINERALS13%
TESCO12%
ROYAL BANK SCOT12%
BP11%

Codes & Symbols

ISINGB00BD6SX109
SymbolsAVO, LSE:AVO, AVO.L, AVO:LN, LON:AVO, XLON:AVO